Portsmouth, NH – Colliers International, a global leader in commercial real estate services, represented Novocure, Inc. in the sublease of 19,000 SF of Class A office space at 135 Commerce Way in Portsmouth, NH. The company now leases a total of 54,000 SF in two buildings at Portsmouth Office Park. Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. David Choate of Colliers’ Portsmouth office represented Novocure and Joe Doyle of CRESA Partners of Boston represented the Sublessor, Liberty Mutual.
Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. It has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The newly leased space in Portsmouth expands Novocure’s U.S. Operating Center. The company has hired over 150 local employees since it first relocated to 195 Commerce Way in Portsmouth in December 2011.
Mike Ambrogi, Novocure’s Chief Operating Officer, said Novocure chose to expand again in Portsmouth because it offers a great quality of life while providing access to the robust Greater Boston life sciences community. Ambrogi also said that the need for additional space reflects Novocure’s increasing commercial and clinical activities in the United States.